FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

46843002: Xanthine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
78078018 Xanthine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
784236011 Xanthine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2699101000005112 Xanthin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xanthine Is a Puriner og derivater false Inferred relationship Some
Xanthine Is a Simple physiological organic compound false Inferred relationship Some
Xanthine Is a Intermediary product of metabolism true Inferred relationship Some
Xanthine Is a Allergen class false Inferred relationship Some
Xanthine Is a Vasodilator (substance) false Inferred relationship Some
Xanthine Is a Drug allergen false Inferred relationship Some
Xanthine Is a Drug pseudoallergen by function false Inferred relationship Some
Xanthine Is a Drug allergen false Inferred relationship Some
Xanthine Is a Xanthine or xanthine derivative false Inferred relationship Some
Xanthine Is a Xanthine and/or xanthine derivative (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
theophyllin kapsel med modificeret udløsning a 300 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin kapsel med modificeret udløsning a 50 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin 600 mg vandfri tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing diprophylline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
acetylsalicylsyre + caffein + orphenadrincitrat tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing caffeine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Caffeine-containing product in rectal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing caffeine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
aminophyllin tablet med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Aminophylline-containing product in rectal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Aminophylline 250 mg rectal suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing precisely aminophylline 500 milligram/1 each conventional release rectal suppository (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Aminophylline 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
aminophyllin 105 mg/5 ml oral væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing diprophylline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Diprophylline-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
dyphyllin 300 mg + guaifenesin 300 mg væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
theophyllin med modificeret udløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Theophylline-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing caffeine and ergotamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
acetylsalicylsyre + butalbital + caffein + codeinphosphat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing ephedrine and theophylline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
paracetamol + caffein + isometheptenmucat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing diprophylline and guaifenesin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing potassium iodide and theophylline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
acetylsalicylsyre + caffein + dihydrocodeinbitartrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing caffeine and sodium benzoate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing butalbital and caffeine and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
ephedrinsulfat + hydroxyzinhydrochlorid + theophyllin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
acetylsalicylsyre + caffein + orphenadrincitrat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
paracetamol + butalbital + caffein + codeinphosphat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing guaifenesin and theophylline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Product containing aspirin and butalbital and caffeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
aminophyllinhydrat tablet med modificeret udløsning a 350 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
aminophyllinhydrat tablet med modificeret udløsning a 225 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
aminophyllinhydrat tabletter med modificeret udløsning a 100 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Some
Urine xanthine level (procedure) Component False Xanthine Inferred relationship Some 2
Pamabrom Is a False Xanthine Inferred relationship Some
Allergy to xanthine Causative agent True Xanthine Inferred relationship Some 1
Xanthine overdose Causative agent True Xanthine Inferred relationship Some 1
Xanthine adverse reaction Causative agent True Xanthine Inferred relationship Some 1
Urine xanthine level (procedure) Component True Xanthine Inferred relationship Some 1

Start Previous Page 3 of 3


This concept is not in any reference sets

Back to Start